By The PRISME Forum

"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise t...

By Dr Julia Schuler and Dr Louise Brackenbury

For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) ha...

By Lubna Hussain

Increasing clinical success by implementing improved methodologies in early phase drug discovery. Using primary cells and 3D culture models to enha...

By Dr Andrew LeBeau

Adoption of a scientific informatics system is essential to the success of every drug discovery organisation.

By Dr Gary Allenby

Application of new assay technologies to shed light on kinase drug discovery.

By Ibis Sanchez- Serrano, Dr Tom Pfeifer and Dr Rathnam Chaguturu

This article is part 1 of 2, and covers tools, technologies and the core model.

By Dr Paul Avery and Dr Richard Massey

CRISPR-Cas9 has rapidly transformed our ability to perform targeted gene editing. While the technique has received much interest for its potential ...

By Dr Azusa Tanaka and Dr Michael Seiler

Regulatory approval of CAR-T cell therapies in 2017 placed the spotlight on immunotherapy approaches that use live cells to attack tumours – a ma...

Thermo Fisher Scientific, has unveiled advances in its leading mass spectrometry portfolio that make these powerful technologies more accessible to...

Highly experienced pharma/biotech professional to lead Avacta’s Board

IONTAS signs collaboration agreement with LG Chem, Ltd. to identify therapeutic oncology leads

Fujifilm completes acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media

Much needed more efficient manufacturing processes aren't being completed by pharma for ADCs

Enamine and BioSolveIT collaboration exceeds expectations to deliver 3.8bn new compounds on demand

Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands

Dates: 20-24 June 2018
Venue: Melbourne, Australia

Dates: 9-10 October 2018
Venue: London, UK